IsoRay, Inc. Gains 39.29%
Mon, Jan 11, 2021 at 05:30 PM
IsoRay, Inc. (ISR:NYSEMKT) soared at $1.95, representing a gain of 39.3%. The stock appeared on our News Catalysts scanner on Thu 07 Jan 21 at 10:04 AM in the 'MISCELLANEOUS' category. From Mon 28 Dec 20, the stock recorded 37.50% Up Days and 22.22% Green Days
The stock spiked on Wed 06 Jan 21 at $2 with a volume of 253M+.
About IsoRay, Inc. (ISR:NYSEMKT)
IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 92.15%
- Sify Technologies Limited (SIFY:NASDAQ), 79.25%
- Avinger, Inc. (AVGR:NASDAQ), 61.9%
- TransEnterix, Inc. (TRXC:NYSEMKT), 43.1%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 42.22%
- IsoRay, Inc. (ISR:NYSEMKT), 39.29%
- JUPW (JUPW:NASDAQ), 36.46%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 34.43%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 34.02%
- Ekso Bionics Holdings, Inc. (EKSO:NASDAQ), 32.95%